The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

NCT05908019 | Unknown

• 1 other identifier: NDMC
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by an elevation in pulmonary artery pressures and pulmonary vascular resistance. The condition most often is rarely detected, and patients frequently suffer symptoms for several years before being appropriately diagnosed. Patients with PH suffer from several symptoms, such as exertional dyspnea, fatigue, weakness, chest pain, fainting…et al. Pulmonary hypertension is an incurable and progressive disease with complex symptoms and treatments. Patients must learn to deal with their unpredictable future and manage the complex treatments associated with severe adverse effects and need significant changes in lifestyle. Therefore, it is important to assist patients to develop the ability of symptom management.

Conditions

Web-based Health Care Program

Outcome Measures

Primary Outcomes (1)

• Pulmonary Arterial Hypertension Symptom

  Pulmonary Arterial Hypertension Symptom Interference Scale, PAHSS, The 10-point Likert scale higher scores mean a worse outcome.

  Change from Baseline pulmonary Arterial Hypertension Symptom at six months

Secondary Outcomes (3)

• Social support

  Change from Baseline social support at six months

• Activity ability

  Change from Baseline activity ability at six months

• Pulmonary Hypertension Quality of life

  Change from Baseline quality of life at six months

Study Arms (2)

Web-based health care program

EXPERIMENTAL

We aim to develop a PAH web-based health care program, and to evaluate the effects of this program on ameliorating social support, self-care ability and active tolerance, and improving symptom distress, anxiety, depression and quality of life in patients with PAH.

Other: Web-based health care program

Usual care

NO INTERVENTION

usual care

Interventions

Web-based health care program OTHER

According to the participants' feedback and recommends, we will modify this program to make it more suitable. In the second and third years, we will conduct a parallel-group, double blind, and block randomization, experimental design study to examine the effectiveness of the Pulmonary Hypertension Web-Based Care Program on the improvements of patients' social support, self-care ability, active tolerance, symptom distress, depression, anxiety and quality of life in patients with PAH.

Web-based health care program

Eligibility Criteria

• Age: 20 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• At least 20 years old, diagnosed by clinical specialists as patients with pulmonary hypertension (Group1 and Group 4)
• Clear consciousness, able to communicate in Mandarin and Taiwanese, with normal hearing
• Those who have internet or mobile internet at home
• Adults without mental illness
• No alcohol or drug abusers.

You may not qualify if:

• \. critical disease

Sponsors & Collaborators

• National Defense Medical Center, Taiwan: lead

Study Sites (1)

Tri-Service General Hospital

Taipei, Taiwan, Taipei, 114, Taiwan

RECRUITING

Central Study Contacts

Chen miao-yi, PhD Stusent

CONTACT

0955762820; miaoyi820@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 1, 2023
• First Posted: June 18, 2023
• Study Start: May 5, 2023
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: June 18, 2023

Record last verified: 2023-06

Locations

TW (1)